325 related articles for article (PubMed ID: 21471531)
1. Identification of efflux pump-mediated multidrug-resistant bacteria by the ethidium bromide-agar cartwheel method.
Martins M; Viveiros M; Couto I; Costa SS; Pacheco T; Fanning S; Pagès JM; Amaral L
In Vivo; 2011; 25(2):171-8. PubMed ID: 21471531
[TBL] [Abstract][Full Text] [Related]
2. Bacterial efflux pump inhibition.
Kaatz GW
Curr Opin Investig Drugs; 2005 Feb; 6(2):191-8. PubMed ID: 15751743
[TBL] [Abstract][Full Text] [Related]
3. An instrument-free method for the demonstration of efflux pump activity of bacteria.
Martins M; Santos B; Martins A; Viveiros M; Couto I; Cruz A; Pagès JM; Molnar J; Fanning S; Amaral L; ; ;
In Vivo; 2006; 20(5):657-64. PubMed ID: 17091774
[TBL] [Abstract][Full Text] [Related]
4. Screening for efflux pump systems of bacteria by the new acridine orange agar method.
Martins A; Amaral L
In Vivo; 2012; 26(2):203-6. PubMed ID: 22351659
[TBL] [Abstract][Full Text] [Related]
5. The emergence of clinical resistance to tigecycline.
Sun Y; Cai Y; Liu X; Bai N; Liang B; Wang R
Int J Antimicrob Agents; 2013 Feb; 41(2):110-6. PubMed ID: 23127485
[TBL] [Abstract][Full Text] [Related]
6. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
Hasdemir U
Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic resistance--experience in a tertiary care hospital in south India.
Subbalaxmi MV; Lakshmi V; Lavanya V
J Assoc Physicians India; 2010 Dec; 58 Suppl():18-22. PubMed ID: 21568007
[No Abstract] [Full Text] [Related]
8. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
Alhanout K; Brunel JM; Raoult D; Rolain JM
J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
[TBL] [Abstract][Full Text] [Related]
9. Changing trends in antimicrobial resistance of major bacterial pathogens, 1985-2005: a study from a medical center in northern Taiwan.
Lo WT; Lin WJ; Chiueh TS; Lee SY; Wang CC; Lu JJ
J Microbiol Immunol Infect; 2011 Apr; 44(2):131-8. PubMed ID: 21439516
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of forty new phenothiazine derivatives for activity against intrinsic efflux pump systems of reference Escherichia coli, Salmonella Enteritidis, Enterococcus faecalis and Staphylococcus aureus strains.
Takács D; Cerca P; Martins A; Riedl Z; Hajós G; Molnár J; Viveiros M; Couto I; Amaral L
In Vivo; 2011; 25(5):719-24. PubMed ID: 21753124
[TBL] [Abstract][Full Text] [Related]
11. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
Couto I; Costa SS; Viveiros M; Martins M; Amaral L
J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro evaluation of activity of tigecycline against susceptible and multidrug resistant organisms.
Gupta V; Bansal N; Chander J
Indian J Med Microbiol; 2012; 30(4):483-5. PubMed ID: 23183481
[No Abstract] [Full Text] [Related]
13. Competition between substrates of the efflux pump system of Salmonella enteritidis.
Cerca P; Martins A; Couto I; Viveiros M; Amaral L
In Vivo; 2011; 25(4):597-602. PubMed ID: 21709002
[TBL] [Abstract][Full Text] [Related]
14. The carbon source influences the efflux pump-mediated antimicrobial resistance in clinically important Gram-negative bacteria.
Villagra NA; Fuentes JA; Jofré MR; Hidalgo AA; García P; Mora GC
J Antimicrob Chemother; 2012 Apr; 67(4):921-7. PubMed ID: 22258924
[TBL] [Abstract][Full Text] [Related]
15. Characterization of intrinsic efflux activity of Enterococcus faecalis ATCC29212 by a semi-automated ethidium bromide method.
Spengler G; Martins A; Schelz Z; Rodrigues L; Aagaard L; Martins M; Costa SS; Couto I; Viveiros M; Fanning S; Kristiansen JE; Molnar J; Amaral L
In Vivo; 2009; 23(1):81-7. PubMed ID: 19368129
[TBL] [Abstract][Full Text] [Related]
16. The role of active efflux in antibiotic - resistance of clinical isolates of Helicobacter pylori.
Falsafi T; Ehsani A; Niknam V
Indian J Med Microbiol; 2009; 27(4):335-40. PubMed ID: 19736403
[TBL] [Abstract][Full Text] [Related]
17. Changing trends in antimicrobial susceptibility and hospital acquired infections over an 8 year period in a tertiary care hospital in relation to introduction of an infection control programme.
Gopalakrishnan R; Sureshkumar D
J Assoc Physicians India; 2010 Dec; 58 Suppl():25-31. PubMed ID: 21563610
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method.
Viveiros M; Martins A; Paixão L; Rodrigues L; Martins M; Couto I; Fähnrich E; Kern WV; Amaral L
Int J Antimicrob Agents; 2008 May; 31(5):458-62. PubMed ID: 18343640
[TBL] [Abstract][Full Text] [Related]
19. Bacterial organisms and antimicrobial resistance patterns.
Varghese GK; Mukhopadhya C; Bairy I; Vandana KE; Varma M
J Assoc Physicians India; 2010 Dec; 58 Suppl():23-4. PubMed ID: 21563609
[TBL] [Abstract][Full Text] [Related]
20. Sensitizing multi drug resistant
Baiomy AA; Shaker GH; Abbas HA
Afr Health Sci; 2020 Dec; 20(4):1632-1645. PubMed ID: 34394224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
